We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Georgina Buck

Georgina Buck

Contact information

Email
georgina.buck@ndph.ox.ac.uk

Georgina Buck

BSc, MSc

Medical Statistician, CTSU

Georgina Buck gained a joint honours degree in Mathematics and Psychology at Nottingham University (1991-1994) and a Master's in Statistics with Applications in Medicine at Southampton University (1994-1995) before joining the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) at Oxford Population Health in 1995.

She worked on the Medical Research Council leukaemia trials until their transfer in 2013-2016 and started working on the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial in 2014.

Recent publications

Active Monitoring for AtriaL FIbrillation (AMALFI): Rationale, protocol, and pilot for a pragmatic, randomized, controlled trial of remote screening for asymptomatic atrial fibrillation

Wijesurendra R. et al, (2025), American Heart Journal, 290, 310 - 324

Remote Screening for Asymptomatic Atrial Fibrillation: The AMALFI Randomized Clinical Trial

Wijesurendra R. et al, (2025), JAMA, 334, 1349 - 1357

Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes

Sammons E. et al, (2025), BMJ Open, 15

ASCEND-Eye: Effects of Aspirin on Diabetic Retinopathy

Sammons EL. et al, (2024), Ophthalmology, 131, 771 - 779

ASCEND-Eye: Effects of Omega-3 Fatty Acids on Diabetic Retinopathy

Sammons EL. et al, (2024), Ophthalmology, 131, 526 - 533